United States · Federal contract register · Supplier record

IMPEL PHARMACEUTICALS INC

Line: Reference laboratory testing (Q301)Register loaded to September 2026Compiled 17 October 2026

IMPEL PHARMACEUTICALS INC — United States · Federal contract register · Supplier record: 9 contracts, all years ($795,575 · Jul 2010 – Jun 2024); $3.8K since January 2024 (2 contracts · 1 agency); — rank in the line (of 753 suppliers · 0.0%); 18 agencies never served ($76.9M on the line without IMPEL PHARMACEUTICALS INC).

Assay record ASY-US-0JDN3OF11A · Cite as: Assay Systems, “IMPEL PHARMACEUTICALS INC: 2 government contracts in the United States since 2024”, https://assay-systems.com/register/us/impel-pharmaceuticals-inc/

9
contracts, all years
$795,575 · Jul 2010 – Jun 2024
$3.8K
since January 2024
2 contracts · 1 agency
—
rank in the line
of 753 suppliers · 0.0%
18
agencies never served
$76.9M on the line without IMPEL PHARMACEUTICALS INC

Own record by year

2023 onward
$7.3K
$3.8K
2023202420252026

Who buys from IMPEL PHARMACEUTICALS INC

since January 2024
1agencies
$3.8Kpaid
100.0%top buyer
Department of Veterans Affairs100.0%
$3,784

Before 2024 only: Department of Defense, Department of Health and Human Services.

Won without a rival

2023-10-17 – 2024-06-10
4uncontested awards
100%of its awards
0without a competition
4single bid

IMPEL PHARMACEUTICALS INC won 4 of its 4 public contract awards in United States without a rival from 2023-10-17 to 2024-06-10, worth $11.1K: 0 without a competition and 4 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Department of Veterans Affairs with 4.

Buyers: Department of Veterans Affairs (4)

Every uncontested award of IMPEL PHARMACEUTICALS INC · United States: all uncontested awards

The line

since January 2024
$1.4Bline value
4,363contracts
21agencies
753suppliers
60.5%held by top ten

Reference laboratory testing (Q301)

$549M
$549M
$303M
202420252026Jan–Sep
—of 753 suppliers
$0IMPEL PHARMACEUTICALS INC in the line
0.0%share of the line

Agencies that buy the line and never bought from IMPEL PHARMACEUTICALS INC

18agencies
965contracts
$76,864,134since January 2024
Department of Justice804 contracts
$26,989,285
Department of Transportation8 contracts
$10,770,118
Department of Homeland Security21 contracts
$10,713,621
Department of the Interior38 contracts
$7,662,232
Court Services and Offender Supervision Agency6 contracts
$7,151,083
Department of State8 contracts
$4,934,793
Department of Labor1 contract
$2,280,000
Department of Agriculture42 contracts
$1,937,806
Executive Office of the President2 contracts
$1,391,038
Department of Energy5 contracts
$1,226,989
Department of Commerce3 contracts
$774,384
Department of the Treasury12 contracts
$378,838
General Services Administration1 contract
$327,268
Smithsonian Institution6 contracts
$130,204
Environmental Protection Agency5 contracts
$113,505
Government Accountability Office1 contract
$38,526
Defense Nuclear Facilities Safety Board1 contract
$26,820
Peace Corps1 contract
$17,625

How the line is bought

by value, since 2024
24%no competition
12%one applicant
0of these to IMPEL PHARMACEUTICALS INC
Competed, several suppliers applied2,055 contracts
$901,579,334 · 64.4%
Awarded directly, no competition1,349 contracts
$334,251,303 · 23.9%
Competed, one supplier applied959 contracts
$164,855,505 · 11.8%

Contracts reaching their end dates

Oct 2026 – October 2027
938contracts
$431,298,704end by October 2027
251end in March 2027 · $95.1M
62in agencies never served · $16.4M
$22.3M
$15.3M
$33.3M
$43.3M
$25.3M
$95.1M
$25.0M
$11.5M
$20.8M
$28.3M
$9.4M
$102M
Oct 2627 contractsNov 2652 contractsDec 2670 contractsJan 2751 contractsFeb 2753 contractsMar 27251 contractsApr 2764 contractsMay 2746 contractsJun 2766 contractsJul 2765 contractsAug 2756 contractsSep 27137 contracts

Fastest-growing supplier in the line

same line
+34%growth

Supplier UEI NHYWLYK6NBM8

2024 to Sep 2026
$292,229,334
2022–2023
$217,743,208

The extract

Every buying office, every contract holder, value, number and end date behind the figures above.

Request extractSee a sample extract

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.